Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-05-11

Clinical Trial Update: Modulation of the Intestinal Flora With the Probiotic VIVOMIXX™ in Pregnant Women at Risk of Metabolic Complications [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the probiotic VIVOMIXX in pregnant women at risk of metabolic complications, including gestational diabetes mellitus. The status of the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vivomixx (Probiotic formulation)

Snippet

Sponsor: University of Modena and Reggio Emilia | Conditions: Gestational Diabetes Mellitus in Pregnancy, Diet- Controlled, Exercise Addiction | Phase 3 | Status: UNKNOWN